Nitay Ad-El

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Immune Response

Top Venues

Science advances

Nature biotechnology

Nature reviews. Clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Si-Kun Guo, Chu-Xiao Liu, Yi-Feng Xu, Xiao Wang, Fang Nan, Youkui Huang, Siqi Li, Shan Nan, Ling Li, Edo Kon, Chen Li, Meng-Yuan Wei, Rina Su, Jia Wei, Shiguang Peng, Nitay Ad-El, Jiaquan Liu, Dan Peer, Ting Chen, Li Yang, Ling-Ling Chen
Therapeutic application of circular RNA aptamers in a mouse model of psoriasis. Nature biotechnology (2024)
Edo Kon, Yinon Levy, Uri Elia, Hila Cohen, Inbal Hazan-Halevy, Moshe Aftalion, Assaf Ezra, Erez Bar-Haim, Gonna Somu Naidu, Yael Diesendruck, Shahar Rotem, Nitay Ad-El, Meir Goldsmith, Emanuelle Mamroud, Dan Peer, Ofer Cohen
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Science advances 9 (10) (2023)
Edo Kon, Nitay Ad-El, Inbal Hazan-Halevy, Lior Stotsky-Oterin, Dan Peer
Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects. Nature reviews. Clinical oncology (2023)
Edo Kon, Yinon Levy, Uri Elia, Hila Cohen, Inbal Hazan-Halevy, Moshe Aftalion, Assaf Ezra, Erez Bar-Haim, Gonna Somu Naidu, Yael Diesendruck, Shahar Rotem, Nitay Ad-El, Meir Goldsmith, Emanuelle Mamroud, Dan Peer, Ofer Cohen
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Science advances 9 (10) (2023)
Edo Kon, Yinon Levy, Uri Elia, Hila Cohen, Inbal Hazan-Halevy, Moshe Aftalion, Assaf Ezra, Erez Bar-Haim, Gonna Somu Naidu, Yael Diesendruck, Shahar Rotem, Nitay Ad-El, Meir Goldsmith, Emanuelle Mamroud, Dan Peer, Ofer Cohen
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Science advances 9 (10) (2023)
Edo Kon, Yinon Levy, Uri Elia, Hila Cohen, Inbal Hazan-Halevy, Moshe Aftalion, Assaf Ezra, Erez Bar-Haim, Gonna Somu Naidu, Yael Diesendruck, Shahar Rotem, Nitay Ad-El, Meir Goldsmith, Emanuelle Mamroud, Dan Peer, Ofer Cohen
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Science advances 9 (10) (2023)